Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675608 · ClinicalTrials.gov registry record
Vaccine Efficacy in Diabetic and Elderly Patients
A clinical trial of Inflammation, sponsored by Tulane University.
- Completed
- Registry status
- 164
- Enrollment target
- 1
- Study location
NCT02675608: Completed study of Inflammation, sponsored by Tulane University.
NCT02675608 is a study of Inflammation that has completed, run by Tulane University. The registered enrollment target is 164 participants, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02675608, a study of Inflammation, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effectiveness of the seasonal flu vaccine in adults of different ages and diabetic disease statuses. These studies will help our understanding of how chronic inflammatory diseases impact immunologic function and future research on mitigation strategies.
Primary Outcome
Blood samples collected days 0 and 30 will be evaluated and compared for flu antibodies using the standards HAI assay with individual virus strains contained in vaccine.
Conditions Studied
Interventions
- BIOLOGICAL Influenza Virus Vaccine
Study Locations (1)
Louisiana
- Tulane Clinical Translational Unit - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2015-08 |
What the finished NCT02675608 record still lists
NCT02675608 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Influenza Virus Vaccine is the first listed.
NCT02675608 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT02675608 about?
NCT02675608 is a clinical study titled "Vaccine Efficacy in Diabetic and Elderly Patients". This study evaluates the effectiveness of the seasonal flu vaccine in adults of different ages and diabetic disease statuses. These studies will help our understanding of how chronic inflammatory diseases impact immunologic function and future research on mitigation strategies.
What is the current status of trial NCT02675608?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2015-08.
What conditions does trial NCT02675608 study?
This clinical trial studies the following conditions: Inflammation.
What interventions are being tested in trial NCT02675608?
The interventions under investigation include: Influenza Virus Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02675608?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02675608 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02675608's enrollment target sits among peer trials
164 34th of 132 higher than 99 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia